Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

RPM Reports Fiscal 2022 Second-Quarter Results
RPM Reports Fiscal 2022 Second-Quarter Results


RPM International Inc. (NYSE: RPM), a world leader in specialty coatings and sealants, today announced its financial results for its fiscal 2022 second quarter ended November 30, 2021.

Trane Technologies Schedules Fourth Quarter 2021 Earnings Conference Call: https://brand.tranetechnologies.com/content/dam/cs-corporate/brand-center/logo-black.png
Trane Technologies Schedules Fourth Quarter 2021 Earnings Conference Call


Trane Technologies plc (NYSE:TT), a global climate innovator, will host a conference call to discuss its fourth quarter 2021 financial results on Monday, January 31, 2022, at 10 a.m. ET. The

NICE Named Market Share Leader in Workforce Optimization
NICE Named Market Share Leader in Workforce Optimization


NICE (Nasdaq: NICE) today announced that it has been recognized as the overall market share leader for total workforce optimization (WFO) by DMG Consulting LLC. The ‘Contact Center Workforce

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the

Houlihan Lokey Further Expands Oil and Gas Coverage Into Middle East
Houlihan Lokey Further Expands Oil and Gas Coverage Into Middle East


Houlihan Lokey (NYSE:HLI), the global investment bank, announced today the expansion of its global Oil & Gas team into the Middle East with the appointment of Rouzbeh Fazlinejad as a Managing

DGAP-News: Amex Reviews 2021 Accomplishments and Announces Exploration Plans for 2022
DGAP-News: Amex Reviews 2021 Accomplishments and Announces Exploration Plans for 2022
DGAP-News: Amex Reviews 2021 Accomplishments and Announces Exploration Plans for 2022
EQS-News: Nordea Bank Abp: Transaction in Own Shares
EQS-News: Nordea Bank Abp: Transaction in Own Shares
EQS-News: Nordea Bank Abp: Transaction in Own Shares
DGAP-News: Steinhoff International Holdings N.V. : PEPCO GROUP N.V.
DGAP-News: Steinhoff International Holdings N.V. : PEPCO GROUP N.V.
DGAP-News: Steinhoff International Holdings N.V. : PEPCO GROUP N.V.
Guess?, Inc. Announces Participation at the 24th Annual ICR XChange Conference
Guess?, Inc. Announces Participation at the 24th Annual ICR XChange Conference


Guess?, Inc. (NYSE: GES) announced today that the Company will be participating in a virtual fireside chat at the 24th Annual ICR XChange Conference on Monday, January 10, 2022 at 10:30 a.m

Sangamo Therapeutics Announces Participation at H.C. Wainwright BIOCONNECT Virtual Conference
Sangamo Therapeutics Announces Participation at H.C. Wainwright BIOCONNECT Virtual Conference


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will provide a corporate presentation at the H.C. Wainwright BIOCONNECT Virtual Conference on

Lomiko Announces Corporate Update, Investor Relations Representation and Membership in The Accelerate Alliance
Lomiko Announces Corporate Update, Investor Relations Representation and Membership in The Accelerate Alliance


Lomiko Metals Inc. (TSX.V:LMR) (“Lomiko Metals” or the “Company”) is pleased to announce the following corporate updates as it builds on the significant momentum of its 2021 activities.



Belinda

Quidel to Present at 40th Annual J.P. Morgan Healthcare Conference
Quidel to Present at 40th Annual J.P. Morgan Healthcare Conference


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 40th

State Street Corporation Announces Date for Release of Fourth-Quarter and Full-Year 2021 Financial Results and Conference Call Webcast
State Street Corporation Announces Date for Release of Fourth-Quarter and Full-Year 2021 Financial Results and Conference Call Webcast


State Street Corporation (NYSE: STT) plans to announce its fourth-quarter and full-year 2021 financial results on Wednesday, January 19, 2022 at approximately 7:30 a.m. ET. The results will be

Diodes Incorporated to Present at the Needham Growth Conference on January 13
Diodes Incorporated to Present at the Needham Growth Conference on January 13


Diodes Incorporated (Nasdaq: DIOD), today announced Brett Whitmire, Chief Financial Officer; Emily Yang, Senior Vice President of Worldwide Sales and Marketing; and Gurmeet Dhaliwal, Director of

Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 2022
Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 2022


Regulatory News:



NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities

Roku Chief Financial Officer to Present at Citi’s 2022 AppsEconomy Virtual Conference
Roku Chief Financial Officer to Present at Citi’s 2022 AppsEconomy Virtual Conference


Roku, Inc. (Nasdaq: ROKU) announced today that Chief Financial Officer Steve Louden will present at the Citi 2022 AppsEconomy Conference (formerly TMT West) on Thursday, January 6, 2022. Louden is

Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences
Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences


Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences.




  • H.C. Wainwright

Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference
Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference


Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that

McGrath RentCorp Acquires Texas-Based Container Rental Company
McGrath RentCorp Acquires Texas-Based Container Rental Company


McGrath RentCorp today announced it has acquired the assets of Titan Storage Containers, LLC, a regional provider of portable storage solutions in the Texas market. The transaction was funded with

Puma Biotechnology to Present at the H.C. Wainwright BioConnect Conference
Puma Biotechnology to Present at the H.C. Wainwright BioConnect Conference


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of

Apple Hospitality REIT Announces Dates for Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
Apple Hospitality REIT Announces Dates for Fourth Quarter and Full Year 2021 Earnings Release and Conference Call


Apple Hospitality REIT, Inc. (NYSE: APLE) (the “Company” or “Apple Hospitality”) today announced that it plans to report fourth quarter and full year 2021 financial results after the market closes

Poxel Announces Financial Calendar for 2022
Poxel Announces Financial Calendar for 2022


POXEL SA (Euronext – POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including non-alcoholic

Median Technologies: Financial Communications Schedule for the First Half of 2022
Median Technologies: Financial Communications Schedule for the First Half of 2022


Regulatory News:



Median Technologies (Paris:ALMDT) (ALMDT:PA), announces the publication date for its 2021 results:


Publication


Date


2021 results


April 26, 2022*

Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19
Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19


Pfizer Inc. (NYSE: PFE) announced that the U.S. government has committed to purchasing an additional 10 million treatment courses of its COVID-19 oral therapy, PAXLOVID™ (nirmatrelvir [PF-07321332]

DGAP-News: BP p.l.c.: Total Voting Rights
DGAP-News: BP p.l.c.: Total Voting Rights
DGAP-News: BP p.l.c.: Total Voting Rights